Completed EARLY_PHASE1 INTERVENTIONAL NCT00377845

Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.

Sponsor: University of Aarhus

Conditions Uterine Cervical Dysplasia Uterine Cervical Neoplasms

Interventions Regular Tampax used in 3 hours

Updated 6 times since 2017 Last updated: Mar 26, 2008 Started: Sep 30, 2006 Primary completion: Dec 31, 2007 Completion: Mar 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Uterine Cervical Dysplasia and Uterine Cervical Neoplasms, this trial is completed. The trial is conducted by University of Aarhus and has accumulated 6 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Randers, Denmark